Zhang, Jennifer Q.
Dos Anjos, Carlos Henrique
Sevilimedu, Varadan
Crown, Angelena
Amoroso, Kimberly A.
Pilewskie, Melissa L.
Robson, Mark E.
Gemignani, Mary L.
Funding for this research was provided by:
NIH/NCI Cancer Center Support Grant (P30CA008748)
Article History
Received: 31 May 2023
Accepted: 23 June 2023
First Online: 3 September 2023
Disclosures
: Dr. Mark E. Robson reports uncompensated provision of services to Artios Pharma Limited, AstraZeneca, Tempus Labs, Inc., Pfizer, Inc., and Zenith Pharma, Inc., and honoraria from Clinical Education Alliance, LLC, Genome Quebec, MJH Associates, Physicians’ Education Resources, and Change Healthcare Inc. Dr. Carlos Henrique Dos Anjos reports the following speaking engagements: AstraZeneca, Daiichi-Sankyo, Pfizer, MDHealth, Springer Healthcare, MSD, Roche, Lilly, Gilead, and Fleury. All other authors have no conflicts of interest to disclose.